Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluating vitamin D repletion in patients with Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia [Phase 2]
Phase 2 trial update of sarizotan for L-dopa-induced dyskinesia in Parkinson's disease; the study has completed.
-
FDA approval · 2017-01-23FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves an original application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's [Phase 3]
Phase 3 trial evaluating ropinirole CR as add-on therapy to levodopa in Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2017-01-13Clinical Trial Update: Effectiveness of Different Approaches for the Rehabilitation of Gait in Patients With Parkinson's Disease [NA]
An ongoing clinical trial update evaluating different rehabilitation approaches to improve gait in patients with Parkinson's disease; no res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation [NA]
This study reports the completion of a clinical trial evaluating mechanical peripheral stimulation as a rehabilitation approach for Parkinso…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Remote Access to Care, Everywhere, for Parkinson Disease [NA]
A completed study evaluated remote access to care for people with Parkinson disease, with results posted in January 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects. [Phase 1]
Phase 1 study evaluating [123I]MNI-420 with SPECT as a marker of the adenosine A2a receptor in Parkinson disease, Huntington disease, and he…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions [Phase 1]
Phase 1 PET imaging study of an mGluR5 tracer across several neuropsychiatric conditions has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
A completed clinical trial evaluated norepinephrine transporter blockade as a pathological biomarker in neurogenic orthostatic hypotension a…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: ALTROPANE® SPECT Imaging in Patients With Parkinson Disease [Phase 2]
Phase 2 clinical trial update on ALTROPANE SPECT imaging in patients with Parkinson disease has completed.
-
CLINICAL_TRIALS research · 2016-12-16Clinical Trial Update: Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects [Phase 1]
Phase 1 study evaluating the PET tracer [18F]MNI-777 as a marker of tau pathology in tauopathy subjects and healthy controls has been comple…
-
FDA approval · 2016-12-15FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approved amantadine hydrochloride as an Original Application, enabling generic availability for the drug.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism [Phase 2]
Phase 2 trial update showing results for incobotulinum toxin A (Xeomin) in treating troublesome sialorrhea in Parkinson's disease; results h…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Goal-oriented Intervention in Parkinson's Disease [NA]
Completed clinical trial evaluating a goal-oriented intervention for Parkinson's disease. The study was sponsored by Universidad de Granada.
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153) [Phase 3]
Phase 3 active-controlled extension study updates for Parkinson disease trials have terminated with results posted in 2016.
-
CLINICAL_TRIALS research · 2016-12-08Clinical Trial Update: Understand FoG in PD: Behavioral Physiology and Clinical Application [NA]
This clinical trial update outlines a study on freezing of gait in Parkinson disease, examining behavioral physiology and clinical applicati…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) [Phase 2]
A phase 2 follow-up safety study of SCH 420814 in subjects with Parkinson's disease has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease [Phase 1]
This Phase 1 pharmacokinetic study evaluates the rotigotine patch (Neupro) at weekly doses of 2, 4, 6, and 8 mg/day in patients with early-s…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm
This completed clinical trial investigated motor slowing in Parkinson's disease using a computerized mental chronometry paradigm. Huntington…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation [NA]
This terminated clinical trial investigated the enteric nervous system in Parkinson's disease patients carrying LRRK2 mutations using coloni…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Expiratory Muscle Training for Persons With Neurodegenerative Disease [Phase 2, Phase 3]
A Phase 2/3 trial of Expiratory Muscle Training in people with Parkinson's disease and multiple sclerosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Haptoglobin and Iron in Parkinson's Disease
A clinical trial evaluating the roles of haptoglobin and iron in Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2016-11-29Clinical Trial Update: Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
This clinical trial update outlines a study using the PET imaging tracer [18F]Fluoroethoxybenzovesamicol to evaluate cholinergic innervation…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients [NA]
A completed clinical trial evaluating whether the chin-down swallowing maneuver improves swallowing performance and self-perception in patie…